Analysis of related substances in montelukast sodium granules by HPLC-MS/MS

WANG Yingxin; LIU Ling; LI Shuying; LAN Yi; NIE Lei

doi:10.11665/j.issn.1000-5048.20190309

Journal of China Pharmaceutical University > 2019 > 50(3): 330-336. > DOI: 10.11665/j.issn.1000-5048.20190309

WANG Yingxin, LIU Ling, LI Shuying, LAN Yi, NIE Lei. Analysis of related substances in montelukast sodium granules by HPLC-MS/MS[J]. Journal of China Pharmaceutical University, 2019, 50(3): 330-336. DOI: 10.11665/j.issn.1000-5048.20190309

Citation:

PDF (1516 KB)

Analysis of related substances in montelukast sodium granules by HPLC-MS/MS

More Information

Graphical Abstract

Abstract

Abstract

The aim of this paper was to study the species and sources of related substances in montelukast sodium granules based on HPLC-MS/MS. The related substances of the already marketed montelukast sodium granules(Singulair, 4 mg)were firstly separated and identified by HPLC-MS/MS method, and their chemical structures and sources were confirmed according to the pulished synthesis process and degradation studies. The results revealed that there were 7 related substances, whose chemical structures and sources were confirmed based on the MS/MS technique and the related literature. Impurity 7 , montelukast quinoline ring oxynitride, had not been reported. This study systematically analyzed the related substances in the commercical product, which provides useful information for the development and quality control of the product.
- montelukast sodium,
- montelukast sodium granules,
- singulair,
- related substances,
- HPLC-MS/MS

FullText(HTML)

References (9)

References

[1]	Wang F. Application and clinical effectiveness of montelukast sodium in the treatment of asthma in children[J].J Chin Prescrip Drug(中国处方药),2017,15(3):76-77.
[2]	Zhao QH,Guo F.Clinical efficacy of montelukast sodium in the treatment of asthma in children[J].J Mod Diagn Treat(现代诊断与治疗),2017,28(18):3391-3392.
[3]	Yang J,Li J.Clinical study of montelukast sodium in the treatment of childhood asthma[J].J Pract Med Clin(实用药物与临床),2016,19(5):606-609.
[4]	European Pharmacopoeia Convention.European Pharmacopoeia 8.0[S].Strasbourg:European Directorate for the Quality of Medicines & HealthCare,2013:2794-2796.
[5]	The United States Pharmacopoeial Convention. United States Pharmacopoeia 40[S].Rockville:The United States Pharmacopeial Convention,2017:5220-5222.
[6]	Belley,Leger ML,Labelle S,et al.Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists:US,5565473[P].1996-10-15[2019-02-15] .
[7]	Al Ommri MM.Effect of light and heat on the stability of montelukast in solution and in its solid state[J].J Pharm Biomed Anal,2007,45:465-471.
[8]	Down B.Granule Formation:US,8007830B2[P].2011-08-30[2019-02-15] .
[9]	Zhou LS,Qu HM.Progress in quinoline nitrogen oxide[J].J Chem Propel Poly Mater(化学推进剂与高分子材料),2000(3):9-11.

Cited By

Cited by

Periodical cited type(7)

1.	史丽萍，刘芳，张军，殷俊刚，俞景梅，王可莉，邹冲. 孟鲁司特钠咀嚼片在中国健康受试者中的生物等效性研究. 中国临床药理学杂志. 2025(04): 543-547 .
2.	巩玉钰. 丁酰环磷腺苷钙辅助治疗伴心脏损伤过敏性紫癜患儿的疗效. 甘肃医药. 2023(03): 250-253 .
3.	郝丽娟，苗会娟，韩佳芮，徐欢欢，王茉莉，徐艳梅. 高效液相色谱-串联质谱法同时测定盐酸拉贝洛尔中三种杂质. 化学分析计量. 2023(10): 11-15 .
4.	张磊. 高效液相色谱法测定孟鲁司特钠中有关物质的含量. 中南药学. 2023(12): 3288-3292 .
5.	张琳琳，刘阿利，张继环，王雪，张贵民. 孟鲁司特钠片酸降解未知杂质结构及来源分析. 中南药学. 2022(07): 1564-1568 .
6.	邸翔，葛宾，吴小磊. 维生素D_3联合孟鲁司特钠治疗小儿支气管哮喘临床疗效研究. 创伤与急危重病医学. 2021(05): 361-364 .
7.	万燕. 孟鲁司特钠处方中不同孟鲁司特钠剂型和规格在总处方中出现频次及频率统计及其使用方法和剂量的合理性分析. 医学食疗与健康. 2020(17): 104+125 .

Other cited types(0)

Get Citation

PDF

XML

Article views (531) PDF downloads (1179) Cited by(7)

Turn off MathJax

Article Contents

Abstract

References

Analysis of related substances in montelukast sodium granules by HPLC-MS/MS

Abstract

References

Cited by

Periodical cited type(7)

Other cited types(0)

Catalog

Export File

Citation

Format

Content